Mercer Global Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Buy |
|
|||||
|
2025
Q1 | $2.1M | Buy |
|
|||||
|
2024
Q4 | $1.19M | Buy |
|
|||||
|
2024
Q3 | $574K | Sell |
|
|||||
|
2024
Q2 | $1.01M | Sell |
|
|||||
|
2024
Q1 | $1.07M | Sell |
|
|||||
|
2023
Q4 | $1.21M | Sell |
|
|||||
|
2023
Q3 | $1.13M | Sell |
|
|||||
|
2023
Q2 | $1.35M | Sell |
|
|||||
|
2023
Q1 | $1.52M | Sell |
|
|||||
|
2022
Q4 | $1.69M | Sell |
|
|||||
|
2022
Q3 | $1.52M | Sell |
|
|||||
|
2022
Q2 | $1.6M | Buy |
|
|||||
|
2022
Q1 | $1.49M | Sell |
|
|||||
|
2021
Q4 | $1.71M | Buy |
|
|||||
|
2021
Q3 | $1.45M | Sell |
|
|||||
|
2021
Q2 | $2.01M | Sell |
|
|||||
|
2021
Q1 | $1.83M | Sell |
|
|||||
|
2020
Q4 | $2.33M | Buy |
|
|||||
|
2020
Q3 | $2M | Buy |
|
|||||
|
2020
Q2 | $354K | Buy |
|
|||||
|
2020
Q1 | $239K | Buy |
|
|||||
|
2019
Q4 | $238K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $233K | Buy |
|
|||||
|
2019
Q1 | $235K | Buy |
|